OXiGENE, Inc.
230 Third Avenue
Waltham
Massachusetts
02451
United States
Tel: 781-547-5900
Fax: 781-547-6800
Website: http://www.oxigene.com/
247 articles about OXiGENE, Inc.
-
OXiGENE Reports Third Quarter 2015 Financial Results
11/11/2015
-
OXiGENE Announces Positive Initial Data From Phase Ib Study Of CA4P In Combination With Pazopanib In Patients With Advanced Recurrent Ovarian Cancer
11/6/2015
-
OXiGENE Announces Initiation Of Phase Ib/II Clinical Trial Of Oxi4503 In Acute Myeloid Leukemia
10/22/2015
-
OXiGENE To Present At The 14th Annual BIO Investor Forum
10/19/2015
-
OXiGENE Announces Interim Phase II Data For Lead Clinical Candidate CA4P (Fosbretabulin) In Neuroendocrine Tumors
10/19/2015
-
OXiGENE Announces Plans To Advance CA4P (Fosbretabulin) In Two Late-Stage Clinical Trials
9/30/2015
-
OXiGENE Reports Second Quarter 2015 Financial Results
8/5/2015
-
OXiGENE To Host Second Quarter Financial Results Conference Call And Webcast
7/28/2015
-
OXiGENE Appoints Matthew M. Loar As Chief Financial Officer
7/21/2015
-
OXiGENE Receives Guidance From FDA Supporting Phase III Trial Of Fosbretabulin/Bevacizumab Combination In Platinum-Resistant Ovarian Cancer
6/1/2015
-
OXiGENE Announces Issuance Of U.S. Patent For OXi4503 In Acute Myeloid Leukemia
5/27/2015
-
OXiGENE Appoints Bill Schwieterman, M.D., As President And CEO
5/13/2015
-
OXiGENE Reports First Quarter 2015 Financial Results
5/1/2015
-
OXiGENE Announces Participation In Upcoming Investor And Medical Conferences
4/3/2015
-
OXiGENE Announces $10 Million At-the-Market Registered Direct Offering
3/20/2015
-
OXiGENE Reports Financial Results For 2014
3/18/2015
-
OXiGENE Announces 2014 Financial Results Conference Call And Webcast
3/5/2015
-
OXiGENE Announces Presentation And Webcast At The 27th Annual ROTH Conference On March 11th
2/24/2015
-
OXiGENE Announces Presentation And Webcast At The 17th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference On February 10th
1/27/2015
-
OXiGENE Announces Preclinical Poster Presentation On Oxi4503 At Upcoming American Society of Hematology Meeting
11/20/2014